» Articles » PMID: 33951119

The Interrelationship Among Non-Alcoholic Fatty Liver Disease, Colonic Diverticulosis and Metabolic Syndrome

Overview
Specialty Gastroenterology
Date 2021 May 5
PMID 33951119
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Non-alcoholic fatty liver disease and colonic diverticulosis are widespread, obesity-related diseases. It has recently become clear that non-alcoholic fatty liver disease is a systemic disease and may play a key role in metabolic syndrome; therefore, the term metabolic-dysfunction-associated fatty liver disease has been introduced in the literature. Excess visceral adipose tissue is an important predictor of complications in both non-alcoholic fatty liver disease and colonic diverticulosis. Current evidence suggests that intestinal dysbiosis may be involved in the development of both non-alcoholic fatty liver disease and colonic diverticulosis, and that metabolic syndrome is a consequence rather than a cause of this complex relationship. In this review, our aim was to assess the current knowledge of the complex interplay between metabolic syndrome, non-alcoholic fatty liver disease, and colonic diverticulosis.

Citing Articles

Risk Factors Associated with Postoperative Outcomes in Diverticular Disease Undergoing Elective Colectomy-A Retrospective Cohort Study from the ACS-NSQIP Database.

Hu W, Eisenstein S, Parry L, Ramamoorthy S J Clin Med. 2023; 12(23).

PMID: 38068390 PMC: 10707174. DOI: 10.3390/jcm12237338.


Unraveling the link between insulin resistance and Non-alcoholic fatty liver disease (or metabolic dysfunction-associated steatotic liver disease): A Narrative Review.

Ziamanesh F, Mohammadi M, Ebrahimpour S, Tabatabaei-Malazy O, Mosallanejad A, Larijani B J Diabetes Metab Disord. 2023; 22(2):1083-1094.

PMID: 37975107 PMC: 10638269. DOI: 10.1007/s40200-023-01293-3.


Obesity as a Risk Factor of Severe Outcome of COVID-19: A Pair-Matched 1:2 Case-Control Study.

Russo A, Pisaturo M, Zollo V, Martini S, Maggi P, Numis F J Clin Med. 2023; 12(12).

PMID: 37373748 PMC: 10298877. DOI: 10.3390/jcm12124055.


Type 2 Diabetes Mellitus, Non-Alcoholic Fatty Liver Disease, and Metabolic Repercussions: The Vicious Cycle and Its Interplay with Inflammation.

Frankowski R, Kobierecki M, Wittczak A, Rozycka-Kosmalska M, Pietras T, Sipowicz K Int J Mol Sci. 2023; 24(11).

PMID: 37298632 PMC: 10254034. DOI: 10.3390/ijms24119677.


What's New in the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD).

Kosmalski M, Frankowski R, Ziolkowska S, Rozycka-Kosmalska M, Pietras T J Clin Med. 2023; 12(5).

PMID: 36902639 PMC: 10003344. DOI: 10.3390/jcm12051852.